ArticleJournal of clinical microbiology2010
The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity.
Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Structure-Function Characterization of Streptococcus intermedius Surface Antigen Pas.Journal of bacteriology · 2021Article
- In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.Scientific reports · 2019Article
- The Yin and Yang ofJournal of bacteriology · 2019Review
- Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.Journal of bacteriology · 2019Article
- Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?BMC infectious diseases · 2017Article
- Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.Antimicrobial agents and chemotherapy · 2017Article
- Article
- Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.BMC pulmonary medicine · 2015Article
- Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.BMC pulmonary medicine · 2015Article
- Bacterial pathogens associated with hidradenitis suppurativa, France.Emerging infectious diseases · 2014Article
- Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Clinical microbiology reviews · 2014Review
- Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.BMC infectious diseases · 2014Article
- Cystic fibrosis: a mucosal immunodeficiency syndrome.Nature medicine · 2012Review
- Polymicrobial interactions: impact on pathogenesis and human disease.Clinical microbiology reviews · 2012Review
- Article
- Clinical significance of microbial infection and adaptation in cystic fibrosis.Clinical microbiology reviews · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The genetic relatedness of Streptococcus milleri group isolates from the airways of cystic fibrosis patients was determined by using pulsed-field gel electrophoresis. This study reveals no evidence for patient-to-patient transmission in our patient population; however, within individual patients, complex inter- and intraspecies diversity and dynamics can be observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.